Related Experiment Videos
Endothelial-cell permeability and protein kinase C in pre-eclampsia
Lancet (London, England)
|September 12, 1998
Summary
Serum from pre-eclamptic patients significantly increases endothelial permeability, a key factor in pre-eclampsia pathogenesis. This effect is mediated by protein kinase C (PKC) alpha and epsilon signaling pathways.
Area of Science:
- Obstetrics and Gynecology
- Vascular Biology
- Cell Signaling
Background:
- Pre-eclampsia is characterized by edema and vascular leakage.
- The role of endothelial cell permeability in pre-eclampsia pathogenesis is under investigation.
- Potential serum factors and signaling pathways involved in pre-eclampsia require elucidation.
Purpose of the Study:
- To test the hypothesis that serum from pre-eclamptic patients increases endothelial cell permeability.
- To investigate the signal-transduction pathways involved in this process, particularly protein kinase C (PKC).
Main Methods:
- Studied serum effects on cultured human umbilical vein endothelial cells from various patient groups.
- Measured endothelial permeability using albumin flux assays.
- Investigated protein kinase C (PKC) signaling via inhibitors, down-regulation with phorbol ester, western blot, confocal microscopy, and antisense oligodeoxynucleotides (ODN).
Main Results:
- Serum from pre-eclamptic women significantly increased endothelial permeability by 100% (p<0.01), with rapid normalization post-delivery.
- Serum from normotensive pregnant and non-pregnant women, or those with essential hypertension, had no effect.
- Pre-eclamptic serum induced translocation of PKC alpha and epsilon, and inhibition of PKC signaling pathways (using Goe 6976, staurosporine, or antisense ODN) reduced the permeability increase.
Conclusions:
- Serum from pre-eclamptic patients contains factors that elevate endothelial cell permeability.
- Protein kinase C (PKC) alpha and epsilon signaling pathways are likely mediators of the increased vascular permeability observed in pre-eclampsia.